Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Greiner

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annals of Hematology|July 29, 2021
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusionNeal Shah, Kevin Rakszawski, Myles Nickolich, et al.
British Journal of Haematology|June 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantationClaudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, et al.
Annals of Hematology|December 17, 2022
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxisJoseph Cioccio, Kevin Rakszawski, Hong Zheng, et al.
The Journal of Molecular Diagnostics : JMD|November 27, 2024
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed ChimerismRuoheng Zhang, Yimeng Shang, Joseph Cioccio, et al.
Leukemia Research|June 9, 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantationEmma Zulch, Yoshitaka Inoue, Joseph Cioccio, et al.
Transplantation and Cellular Therapy|March 15, 2022
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy ConsortiumHemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of Hematology|July 29, 2021
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusionNeal Shah, Kevin Rakszawski, Myles Nickolich, et al.
British Journal of Haematology|June 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantationClaudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, et al.
Annals of Hematology|December 17, 2022
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxisJoseph Cioccio, Kevin Rakszawski, Hong Zheng, et al.
The Journal of Molecular Diagnostics : JMD|November 27, 2024
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed ChimerismRuoheng Zhang, Yimeng Shang, Joseph Cioccio, et al.
Leukemia Research|June 9, 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantationEmma Zulch, Yoshitaka Inoue, Joseph Cioccio, et al.
Transplantation and Cellular Therapy|March 15, 2022
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy ConsortiumHemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, et al.
Pageof 2